- Home
- AR vs NBIX Comparison
AR vs NBIX Comparison
Compare AR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AR
- NBIX
- Stock Information
- Founded
- AR 2002
- NBIX 1992
- Country
- AR United States
- NBIX United States
- Employees
- AR N/A
- NBIX N/A
- Industry
- AR Oil & Gas Production
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AR Energy
- NBIX Health Care
- Exchange
- AR Nasdaq
- NBIX Nasdaq
- Market Cap
- AR 12.7B
- NBIX 11.0B
- IPO Year
- AR 2013
- NBIX 1996
- Fundamental
- Price
- AR $34.42
- NBIX $101.38
- Analyst Decision
- AR Buy
- NBIX Strong Buy
- Analyst Count
- AR 18
- NBIX 21
- Target Price
- AR $40.94
- NBIX $163.00
- AVG Volume (30 Days)
- AR 6.1M
- NBIX 1.8M
- Earning Date
- AR 04-30-2025
- NBIX 05-05-2025
- Dividend Yield
- AR N/A
- NBIX N/A
- EPS Growth
- AR N/A
- NBIX 33.20
- EPS
- AR 0.18
- NBIX 3.29
- Revenue
- AR $4,297,764,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- AR $36.14
- NBIX $15.48
- Revenue Next Year
- AR $3.16
- NBIX $15.99
- P/E Ratio
- AR $187.85
- NBIX $30.81
- Revenue Growth
- AR N/A
- NBIX 24.81
- 52 Week Low
- AR $24.53
- NBIX $84.23
- 52 Week High
- AR $42.63
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- AR 44.02
- NBIX 46.65
- Support Level
- AR $32.70
- NBIX $84.23
- Resistance Level
- AR $34.51
- NBIX $112.74
- Average True Range (ATR)
- AR 2.55
- NBIX 5.17
- MACD
- AR -0.36
- NBIX 0.59
- Stochastic Oscillator
- AR 36.35
- NBIX 60.45
About AR Antero Resources Corporation
Antero Resources, based in Denver, engages in the exploration for and production of natural gas and natural gas liquids in the United States and Canada. At the end of 2024, the company reported proven reserves of 17.9 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,424 million cubic feet of equivalent a day in 2024 at a ratio of 35% liquids and 65% natural gas.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.